Optimization of piribedil mucoadhesive tablets for efficient therapy of Parkinson’s disease: physical characterization and ex vivo drug permeation through buccal mucosa

References

• Cagnotto A, Parotti L, Mennini T. In vitro affinity of piribedil for dopamine D3 receptor subtypes, an autoradiographic study. Eur J Pharmacol. 1996;313:63–67.
   PubMed Web of Science ®Google Scholar
• Thobois S, Lhommee E, Klinger H, et al. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain. 2013;136:1568–1577.
   PubMed Web of Science ®Google Scholar
• Jenner P. Parkinson’s disease: pathological mechanisms and actions of piribedil. J Neurol 1992;239:S2–S8.
   PubMed Web of Science ®Google Scholar
• Altschuler RA, Wys N, Prieskorn D, et al. Treatment with piribedil and memantine reduces noise-induced loss of inner hair cell synaptic ribbons. Sci Rep. 2016;6:30821.
   PubMed Web of Science ®Google Scholar
• Demirel M, Yazan Y, Muller RH, et al. Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro- and nanoparticles. J Microencapsul. 2001;18:359–371.
   PubMed Web of Science ®Google Scholar
• Tsai RS, El Tayar N, Carrupt PA, et al. Physicochemical properties and transport behaviour of piribedil: considerations on its membrane-crossing potential. Int J Pharm. 1992;80:39–49.
   Web of Science ®Google Scholar
• Smart JD. Buccal drug delivery. Expert Opin Drug Deliv. 2005;2:507–517.
   PubMedGoogle Scholar
• Madhav NVS, Shakya AK, Shakya P, et al. Orotransmucosal drug delivery systems: a review. J Control Release. 2009;140:2–11.
   PubMed Web of Science ®Google Scholar
• Senel S, Rathbone MJ, Cansiz M, et al. Recent developments in buccal and sublingual delivery systems. Expert Opin Drug Deliv. 2012;9:615–628.
   PubMed Web of Science ®Google Scholar
• Sandri G, Rossi S, Ferrari F, et al. Mucoadhesive polymers as enabling excipients for oral mucosal drug delivery. In: Rathbone MJ, Senel S, Pather I, editors. Oral mucosal drug delivery and therapy. Boston, MA: Springer, 2015. p. 53–88.
   Google Scholar
• Hazzah HA, Farid RM, Nasra MMA, et al. Lyophilized sponges loaded with curcumin solid lipid nanoparticles for buccal delivery: development and characterization. Int J Pharm. 2015;492:248–257.
   PubMed Web of Science ®Google Scholar
• Kianfar F, Ayensu I, Boateng JS. Development and physico-mechanical characterization of carrageenan and poloxamer-based lyophilized matrix as a potential buccal drug delivery system. Drug Dev Ind Pharm. 2014;40:361–369.
   PubMed Web of Science ®Google Scholar
• Okeke OC, Boateng JS. Nicotine stabilization in composite sodium alginate based wafers and films for nicotine replacement therapy. Carbohydr Polym. 2017;155:78–88.
   PubMed Web of Science ®Google Scholar
• Boyapally H, Nukala RK, Bhujbal P, et al. Controlled release from directly compressible theophylline buccal tablets. Colloids Surf B Biointerf. 2010;77:227–233.
   PubMed Web of Science ®Google Scholar
• Gajdziok J, Bajerová M, Chalupová Z, et al. Oxycellulose as mucoadhesive polymer in buccal tablets. Drug Dev Ind Pharm. 2010;36:1115–1130.
   PubMed Web of Science ®Google Scholar
• Laffleur F. Mucoadhesive polymers for buccal drug delivery. Drug Dev Ind Pharm. 2014;40:591–598.
   PubMed Web of Science ®Google Scholar
• Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev. 2005;57:1556–1568.
   PubMed Web of Science ®Google Scholar
• Carlo Ceschel G, Bergamante V, Calabrese V, et al. Design and evaluation in vitro of controlled release mucoadhesive tablets containing chlorhexidine. Drug Dev Ind Pharm. 2006;32:53–61.
   PubMed Web of Science ®Google Scholar
• Movassaghian S, Barzegar-Jalali M, Alaeddini M, et al. Development of amitriptyline buccoadhesive tablets for management of pain in dental procedures. Drug Dev Ind Pharm. 2011;37:849–854.
   PubMed Web of Science ®Google Scholar
• Carr RL. Evaluating flow properties of solids. Chem Eng. 1965;72:163–168.
   Google Scholar
• Hausner HH. Friction conditions in a mass of metal powder. Int J Powder Metall. 1967;3:7–13.
   Google Scholar
• Gönüllü Ü, Gürpınar P, Üner M. Double-layer tablets of lornoxicam: validation of quantification method, in vitro dissolution and kinetic modelling. Trop J Pharm Res. 2015;14:1659–1666.
   Web of Science ®Google Scholar
• Uner M, Celebi B. Design of hydralazine hydrochloride matrix tablets based on various polymers and lipids. Indian J Pharm Educ. 2012;46:75–87.
   Google Scholar
• USP 38 NF 33: United States Pharmacopeia and National Formulary. Rockville, MD: United States Pharmacopeial Convention; 2015.
   Google Scholar
• Mylangam CK, Beeravelli S, Medikonda J, et al. Badam gum: a natural polymer in mucoadhesive drug delivery. Design, optimization, and biopharmaceutical evaluation of badam gum-based metoprolol succinate buccoadhesive tablets. Drug Deliv. 2016;23:195–206.
   PubMed Web of Science ®Google Scholar
• Sogias IA, Williams AC, Khutoryanskiy VV. Chitosan-based mucoadhesive tablets for oral delivery of ibuprofen. Int J Pharm. 2012;436:602–610.
   PubMed Web of Science ®Google Scholar
• Sarati S, Guiso G, Spinelli R, et al. Determination of piribedil and its basic metabolites in plasma by high-performance liquid chromatography. J Chromatogr. 1991;563:323–332.
   PubMed Web of Science ®Google Scholar
• Shanker G, Kumar CK, Gonugunta CSR, et al. Formulation and evaluation of bioadhesive buccal drug delivery of tizanidine hydrochloride tablets. AAPS PharmSciTech. 2009;10:530–539.
   PubMed Web of Science ®Google Scholar
• Sriamornsak P, Thirawong N, Weerapol Y, et al. Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur J Pharm Biopharm. 2007;67:211–219.
   PubMed Web of Science ®Google Scholar
• Jaipal A, Pandey MM, Charde SY, et al. Controlled release effervescent buccal discs of buspirone hydrochloride: in vitro and in vivo evaluation studies. Drug Deliv. 2016;23:452–458.
   PubMed Web of Science ®Google Scholar
• Manuel Llabot J, Manzo RH, allemandi A. Double-layered mucoadhesive tablets containing nystatin. AAPS PharmSciTech. 2002;3:47–52.
   Google Scholar
• Varelas CG, Dixon DG, Steiner CA. Zero-order release from biphasic polymer hydrogels. J Control Release. 1995;34:185–192.
   Web of Science ®Google Scholar
• Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci. 1969;58:1253–1257.
   PubMed Web of Science ®Google Scholar
• Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci. 1961;50:874–875.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.
   Web of Science ®Google Scholar
• Legendre JY, Rault I, Petit A, et al. Effects of β-cyclodextrins on skin: implications for the transdermal delivery of piribedil and a novel cognition enhancing-drug, S-9977. Eur J Pharm Sci. 1995;3:311–322.
   Web of Science ®Google Scholar
• Pitt KG, Heasley MG. Determination of the tensile strength of elongated tablets. Powder Technol. 2013;238:169–175.
   Web of Science ®Google Scholar
• Sarkar D, Nandi G, Changder A, et al. Sustained release gastroretentive tablet of metformin hydrochloride based on poly (acrylic acid)-grafted-gellan. Int J Biol Macromol. 2017;96:137–148.
   PubMed Web of Science ®Google Scholar
• Dadarwal SC, Madan S, Agrawal SS. Formulation and evaluation of delayed-onset extended-release tablets of metoprolol tartrate using hydrophilic-swellable polymers. Acta Pharm. 2012;62:105–114.
   PubMed Web of Science ®Google Scholar
• Nafee NA, Ismail FA, Boraie NA, et al. Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Dev Ind Pharm. 2004;30:985–993.
   PubMed Web of Science ®Google Scholar
• Hassan N, Khar RK, Ali M, et al. Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron. AAPS Pharm Sci Tech. 2009;10:1085.
   PubMed Web of Science ®Google Scholar
• Shivanand K, Raju SA, Nizamuddin S, et al. In vivo bioavailability studies of sumatriptan succinate buccal tablets. Daru. 2011;19:224–230.
   PubMed Web of Science ®Google Scholar
• Kosmidis K, Rinaki E, Argyrakis P, et al. Analysis of Case II drug transport with radial and axial release from cylinders. Int J Pharm. 2003;254:183–188.
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Abdalla OY, Salem H. Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation. AAPS Pharm Sci Tech. 2007;8:156.
   Web of Science ®Google Scholar
• Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery-a promising option for orally less efficient drugs. J Control Release. 2006;114:15–40.
   PubMed Web of Science ®Google Scholar
• Palem CR, Gannu R, Yamsani SK, et al. Development of bioadhesive buccal tablets for felodipine and pioglitazone in combined dosage form: in vitro, ex vivo, and in vivo characterization. Drug Deliv. 2011;18:344–352.
   PubMed Web of Science ®Google Scholar
• El-Nabarawi MA, Ali AA, Aboud HM, et al. Transbuccal delivery of betahistine dihydrochloride from mucoadhesive tablets with a unidirectional drug flow: in vitro, ex vivo and in vivo evaluation. DDDT. 2016;10:4031–4045.
   PubMed Web of Science ®Google Scholar